Bronschhofen / Neuchâtel, Switzerland, 11 November 2026 – Cicor Group and the Swiss technology innovation centre CSEM have entered a strategic, non-exclusive partnership to accelerate the development of medical devices and wearable health technologies. By combining CSEM's expertise in vital signs sensing technologies and algorithms with Cicor's engineering, industrialisation and manufacturing capabilities, the collaboration aims to help customers turn innovative concepts into reliable, scalable products.

The partnership combines expertise across the medical device development process, from early-stage innovation to series production. Andreas Thomann, VP Engineering Services at Cicor, says: "Bringing a new medical technology into series production requires more than an innovative concept. Manufacturing requirements, reliability and scalability need to be considered from the earliest development stages. Our partnership with CSEM allows us to address these challenges together, helping customers reduce development risks and accelerate time-to-market."

CSEM contributes its expertise in advanced vital signs sensing technologies and algorithms for health, wellness and sports applications. Cicor complements these capabilities with product development, system integration, industrialisation and manufacturing know-how for medical electronic systems and complete devices. Josef Hayoz, Senior Manager Medtech at CSEM, says: "By combining CSEM's expertise in vital signs sensing, physiological signal processing and digital health technologies with Cicor's product realisation and industrialisation capabilities, we can offer customers a more integrated path from deep-tech innovation to scalable products."

The intended collaboration addresses customer needs in wearable health monitoring, vital signs sensing, connected medical devices and customer-specific development projects, from initial feasibility studies and prototypes to product development and industrialisation.

The strategic, non-exclusive partnership provides a flexible framework for collaboration. Specific development and manufacturing projects will be agreed separately based on customer requirements, allowing both organisations to combine their expertise and tailor solutions to individual needs.
About CicorThe Cicor Group is a globally active provider of full-cycle electronic solutions from research and development to manufacturing and supply chain management. Cicor's approximately 4,800 employees in 14 countries are serving leaders from the medical, industrial and aerospace & defence industries. Cicor creates value for its customers through the combination of customer-specific development solutions, high-tech components, as well as electronic device manufacturing. The shares of Cicor Technologies Ltd. are traded at the SIX Swiss Exchange (CICN). www.cicor.com
About CSEMCSEM is a Swiss technology innovation centre that develops and transfers advanced technologies with  high societal impact to industry. The non-profit orientated, public-private organization is internationally recognized, and works to support the disruptive activities of companies in Switzerland and abroad. CSEM operates in the domains of precision manufacturing, digitalisation, and sustainable energy. In digital health and medtech, CSEM builds sensing systems and multimodal wearables and develops electronics, embedded software, data and AI algorithms to support next-generation health and wellbeing applications. CSEM's Medtech business unit is ISO 13485:2016 certified. The company has over 600 employees and seven sites in Switzerland. www.csem.ch